Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NDUFA4L2 |
| Upstream (Parents) |
|---|
| (<<) AQP9 → NDUFA4L2 |
| (<<) CYP27A1 → NDUFA4L2 |
| (<<) SLC6A12 → NDUFA4L2 |
| (<<) NDRG1 → NDUFA4L2 |
| Downstream (Children) |
|---|
| NDUFA4L2 → MOS (>>) |
| NDUFA4L2 → ADAMTS6 (>>) |
| NDUFA4L2 → CHRNG (>>) |
| NDUFA4L2 → HLA-DQB1 (>>) |
| NDUFA4L2 → FGF20 (>>) |
| NDUFA4L2 → LOC100287328///RPS29P28 (>>) |
| NDUFA4L2 → ARVCF (>>) |
| NDUFA4L2 → IL1RL2 (>>) |
| NDUFA4L2 → CIITA (>>) |
| NDUFA4L2 → TTC21B (>>) |
| NDUFA4L2 → PPP3CC (>>) |
| NDUFA4L2 → NXPH4 (>>) |
